Clustering data with hclust algorithm for Effects of NO Donor Therapy on the Dystrophic Mouse Muscle Non-Esterified Fatty Acids (part V) (Study ST000649)
Reversed phase NEGATIVE ION MODE (Analysis AN000981)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 |
|---|---|---|---|---|---|---|---|
| Stearic | ME175541 | 1.01 | 1.11 | 1.13 | 0.93 | 0.95 | 0.88 |
| Linoleic | ME175537 | 1.08 | 0.95 | 1.16 | 0.82 | 0.94 | 1.06 |
| Linolenic | ME175531 | 1.12 | 1.00 | 1.04 | 0.84 | 0.96 | 1.04 |
| Oleic | ME175539 | 1.11 | 1.00 | 1.08 | 0.82 | 0.97 | 1.01 |
| Palmitic | ME175538 | 1.09 | 1.00 | 1.01 | 0.93 | 1.02 | 0.95 |
| Arachidonic | ME175535 | 1.21 | 0.99 | 1.00 | 0.84 | 1.06 | 0.90 |
| DHA | ME175532 | 1.15 | 1.02 | 1.00 | 0.83 | 1.07 | 0.94 |
| EPA | ME175530 | 1.28 | 1.12 | 0.77 | 0.92 | 0.99 | 0.93 |
| Myristic | ME175533 | 1.45 | 1.13 | 0.87 | 0.72 | 0.87 | 0.95 |
| Palmitoleic | ME175534 | 1.26 | 1.19 | 0.92 | 0.79 | 0.91 | 0.94 |
Factors:
| F1 | Time point:Post Run | Grouping:RUN-Naproxcinod |
| F2 | Time point:Post Run | Grouping:RUN-Naproxen |
| F3 | Time point:Post Run | Grouping:RUN-Vehicle |
| F4 | Time point:Sedentary | Grouping:SED-Naproxcinod |
| F5 | Time point:Sedentary | Grouping:SED-Naproxen |
| F6 | Time point:Sedentary | Grouping:SED-Vehicle |
